Fudan University: Lung Neoplasms trials

The registry lists 32 Lung Neoplasms studies with Fudan University as lead sponsor. 15 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 13Phase 3 4No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Olive Oil Before Lung Cancer Surgery to Prevent ChylothoraxRecruitingNCT07807696Not applicable
• Association Between Screening Behaviors and Lung Cancer SpectrumRecruitingNCT07626177
• Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLCRecruitingNCT07554846Phase 3
• Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLCRecruitingNCT07398937Phase 2
• Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung CancerRecruitingNCT06684418
• Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer With the CTR of 0.5-1 and the Diameter of ≤ 2 cmRecruitingNCT06634979Not applicable
• AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain MetastasesRecruitingNCT06604689
• Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLCRecruitingNCT06369181
• Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung CancerRecruitingNCT06349252
• Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)Not yet recruitingNCT06323148Phase 3
• Thoracic Consolidation Radiotherapy for ES-SCLC Treated With Chemo-immunotherapyRecruitingNCT06187740Phase 1
• Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)Not yet recruitingNCT06102161Phase 3
• A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal MetastasisNot yet recruitingNCT05359393Phase 2
• Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes in NSCLC (ECTOP-1010)RecruitingNCT05094882
• Adjuvant Chemotherapy for High Risk Stage I Lung AdenocarcinomaRecruitingNCT03380468Phase 2/3
• HTA of NIVATS Based on RWECompletedNCT06574295
• Perioperative Immunotherapy for NSCLC (ECTOP-1030)WithdrawnNCT06572722Phase 2
• A Study of Lymph Node Metastatic Pattern Based Incorporating Tumor Location, GGO Components and Size for Non-small Cell Lung CancerCompletedNCT06161935
• Acute and Chronic Pain After Video-assisted Thoracoscopic Surgery for Lung CancerCompletedNCT05478460
• Circulating EV Long RNA Profiles in SCLCStatus unknownNCT05191849Not applicable
• Pyrotinib Combined With Pemetrexed Plus Carboplatin in the First-line TreatmentStatus unknownNCT04706949Phase 2
• Almonertinib/Pemetrexed/Carboplatin in EGFR T790M+ Advanced Lung CancerStatus unknownNCT04592666Phase 2
• Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung CancerStatus unknownNCT03841136Phase 2
• Mediastinal Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC (ECTOP-1003)CompletedNCT03216551
• Acupuncture Research on Lung Cancer Patients With Cancer Related Fatigue（CRF）Status unknownNCT01881516Phase 2
• A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive BiomarkersStatus unknownNCT01860508Not applicable
• ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLCCompletedNCT01810367Phase 2
• The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung CancerCompletedNCT01797913Phase 2
• Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)CompletedNCT01687439Phase 2
• Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer PatientsStatus unknownNCT01192243Phase 2
• Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer PatientsStatus unknownNCT01192230Phase 2
• Study of Concurrent Pemetrexed, Cisplatin and Radiotherapy in Local Advanced Non-Small Cell Lung CancerStatus unknownNCT00846443Phase 1